We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
4301
Galectin Therapeutics
GALT
$188M
$1.36M ﹤0.01%
350,336
-218,354
-38% -$740K
CLRMU
4302
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$1.36M ﹤0.01%
137,884
-359,799
-72% -$3.57M
ALLT icon
4303
Allot
ALLT
$402M
$1.36M ﹤0.01%
91,281
-122,056
-57% -$2.07M
APTV icon
4304
PUT
Aptiv
APTV
$9.95B
$1.36M ﹤0.01%
+9,100
New +$1.42M
NERV icon
4305
Minerva Neurosciences
NERV
$191M
$1.36M ﹤0.01%
97,428
-64,378
-40% -$968K
SRCL
4306
DELISTED
Stericycle Inc
SRCL
$1.35M ﹤0.01%
19,932
-63,412
-76% -$4.38M
MASI
4307
PUT
DELISTED
Masimo
MASI
$1.35M ﹤0.01%
5,000
-15,000
-75% -$4.07M
COVA
4308
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$1.35M ﹤0.01%
138,832
-3,150
-2% -$30.5K
GBTG icon
4309
CALL
American Express Global Business Travel
GBTG
$4.93B
$1.35M ﹤0.01%
1,660,140
-36,492
-2% -$356K
FNCB
4310
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$1.35M ﹤0.01%
162,434
-123,294
-43% -$952K
MTCH icon
4311
Match Group
MTCH
$9.61B
$1.35M ﹤0.01%
8,582
-594,995
-99% -$90.6M
IBER.U
4312
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$1.35M ﹤0.01%
134,735
-195,383
-59% -$1.95M
TRS icon
4313
TriMas Corp
TRS
$1.46B
$1.35M ﹤0.01%
41,589
-209,854
-83% -$6.48M
GLBLU
4314
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$1.35M ﹤0.01%
132,211
-488,191
-79% -$4.87M
PR
4315
Permian Resources
PR
$17.2B
$1.34M ﹤0.01%
200,752
-1,743,200
-90% -$9.5M
CYBR
4316
CALL
DELISTED
CyberArk
CYBR
$1.34M ﹤0.01%
+8,500
New +$1.29M
SENS icon
4317
Senseonics Holdings Inc
SENS
$279M
$1.34M ﹤0.01%
19,778
+2,355
+14% +$160K
PMT
4318
PennyMac Mortgage Investment
PMT
$828M
$1.34M ﹤0.01%
67,954
+18,829
+38% +$369K
BLNK icon
4319
Blink Charging
BLNK
$80.9M
$1.34M ﹤0.01%
46,735
-10,766
-19% -$349K
NVSAU
4320
DELISTED
New Vista Acquisition Corp Unit
NVSAU
$1.33M ﹤0.01%
133,776
-382,624
-74% -$3.82M
CPLG
4321
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$1.33M ﹤0.01%
85,946
+35,916
+72% +$496K
TGTX icon
4322
CALL
TG Therapeutics
TGTX
$7.22B
$1.33M ﹤0.01%
+40,000
New +$1.24M
ANIK icon
4323
Anika Therapeutics
ANIK
$259M
$1.33M ﹤0.01%
31,244
-13,208
-30% -$544K
SDC
4324
CALL
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$1.33M ﹤0.01%
250,000
-150,000
-38% -$931K
MRLN
4325
DELISTED
Marlin Business Services Corp
MRLN
$1.33M ﹤0.01%
+59,807
New +$1.34M

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.